Nevertheless, LRRC19 expression was obviously higher in esophageal carcinoma (ESCA), head and neck cancer (HNSC), and stomach adenocarcinoma (STAD) compared with adjacent normal tissues. Here, LRRC19 is linked to gastric adenocarcinoma.